Page 3 - Bnormal Sleep Pattern News Today

Despite off-label use of naltrexone by some patients with fibromyalgia in clinical practice, data from a randomized trial showed no pain relief advantage with the drug over placebo.

It's important to ask about sleep and provide targeted interventions to improve sleep and quality of life in women with breast cancer, researchers say.

Cross-sectional study with a diverse cohort revealed no effect modification associated with Hispanic ethnicity.

A recent study assessed a combination of aroxybutynin, which has an antimuscarinic effect, and atomoxetine, which has a noradrenergic effect, in treating OSA.

Sleep disorders in people with epilepsy are linked to a significantly increased risk for sudden unexplained death in epilepsy and all-cause mortality, new research shows.

Vivos Therapeutics said on Wednesday the US health regulator has cleared its oral device for severe obstructive sleep apnea, leading a massive rally in the companys shares before the bell.

The FDA said it is alerting patients of a new safety issue with machines made by the group that are used for the treatment of obstructive sleep apnea.

Restricted sleep of around 6 hours per night may be enough of a reduction to increase the risk for impaired insulin sensitivity in women, particularly if they are postmenopausal, suggests a US trial.

Philips said on Thursday it has reached a settlement to resolve one category of legal claims against it following a major recall of its sleep apnea and respiratory devices.

Sleeping 3 or more hours over or under the average sleep duration of 8 hours increases the risk for type 2 diabetes, regardless of other factors, indicates Dutch study analysis.